Amphion Innovations PLC Directorate Change (1696Q)
August 28 2014 - 1:05AM
UK Regulatory
TIDMAMP
RNS Number : 1696Q
Amphion Innovations PLC
28 August 2014
Amphion Innovations plc
Directorate change
London and New York, 28 August 2014 - Amphion Innovations plc
(LSE: AMP) ("Amphion" or the "Company"), the developer of medical
and technology businesses, today announces the appointment of Mr
Miroslaw Izienicki as Non-executive Director with immediate
effect.
Mr Izienicki, age 57, is a career banker with experience of
providing high level corporate finance advisory and M&A
services, particularly in respect of multi-stakeholder engagements
at or near the interface of government and commerce. Mr Izienicki,
after having served as Chief Operating Officer, is currently Senior
Adviser to Gamma Finance LLP, a provider of advisory services to
the alternative investments industry with a focus on illiquid hedge
funds. Previously, he was Managing Director of Fifth Capital Group,
the London-based think tank and leadership counsel. Prior to Fifth
Capital, he was Head of Corporate Finance / M&A at the London
international HQ of The Nikko Securities Co Ltd of Tokyo, one of
the largest Japanese houses. Mr Izienicki is an alumnus of
University of Cambridge and UCL, London.
Miroslaw Izienicki presently holds directorships with Fifth
Capital Limited and its subsidiary undertakings Fifth Capital
Partners Limited and The Bank of Broad Wealth Limited.
Amphion's Chief Executive Officer, Richard Morgan, commented on
the appointment: "We are delighted to welcome Mr. Izienicki to the
Amphion Board. We welcome his experience and expertise and are
confident he will be a key addition to the company."
Save as disclosed above, there are no further details required
to be disclosed pursuant to schedule 2(g) of the AIM rules.
For further information please contact
Amphion Innovations plc
Charlie Morgan,
+1 (212) 210 6224
Novella Communications
Tim Robertson / Ben Heath
+44 020 3151 7008
Panmure Gordon Limited
Freddy Crossley / Duncan Monteith (Corporate Finance)
Charles Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500
Plumtree Capital Limited (Advisor to Amphion)
Stephen Austin
+44 207 183 2493
+1 646 568 7502
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging
companies in the medical and technology sectors, by using a
focused, hands-on company building approach, based on decades of
experience in both the US and UK. Amphion has significant
shareholding in 7 Partner Companies developing proven technologies
targeting substantial commercial marketplaces. The Amphion model
has been refined to optimise the commercialisation of patents and
other intellectual property within the Partner Companies. The
Partner Companies collectively own or control over 200 separately
identified pieces of intellectual property, a number which grows
rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAMMGZRVNKGDZM
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2024 to May 2024
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From May 2023 to May 2024